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Abstract
Patient-reported outcome measures (PROMs) are widely used in the United Kingdom (UK) and internationally to report
and monitor patients’ subjective assessments of their symptoms and functional status and also their quality of life.
Whilst the importance of involving the public in PROM development to increase the quality of the developed PROM
has been highlighted this practice is not widespread. There is a lack of guidance on how public involvement (PI) could
be embedded in the development of PROMs, where the roles can be more complex than in other types of research.
This paper provides a timely review and sets out an emerging framework for fully incorporating PI into PROM
development.
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Introduction
Patient-reported outcome measures (PROMs) are widely
used in the United Kingdom (UK) and internationally to
report and monitor patients’ subjective assessments of
their health. PROMs can be used to measure symptoms,
functional status and quality of life. PROMs were ini-
tially developed for use in research to assess the effect-
iveness of treatments however they are now also used to
assess and compare the outcomes achieved by healthcare
providers [1]. Additionally, PROMs may be used for in-
formation sharing and to support patient decision-
making [2]. The value of incorporating patient input and
the patient’s own perspective on their own quality of life
when designing new PROMs is now almost universally
accepted. PROM developers have moved away from the
historical “top down” methods to “bottom up” method-
ologies, which incorporate qualitative data techniques to
generate content for the PROM itself [3]. Such changes
have improved the content validity of PROMs, ensuring
that the language and terminology are appropriate for
the target population, and the items within the instru-
ment fully assess the impact of the given condition on
quality of life (for example). The Food and Drug Admin-
istration (FDA) guidance on PROM development advo-
cates patient input to inform the content and improve
the relevance and validity of PROMs [4]. Whilst the
guidance advocates the important role of patient input,
it could be argued that this can be met by having pa-
tients or members of the public as research participants
in the early stages of PROM development. However, the
value of using patients or members of the public to ad-
vise on the process of PROM development and help
guide the research is less acknowledged.
There is growing recognition of the value of public in-
volvement (PI) in health research, which has been de-
fined as “research being carried out with or by members
of the public” [5]. In this context, the term “public” in-
cludes patients, potential patients, carers and people
who use health and social care services, as well as orga-
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nisations that represent people who use these services [5].
The use of the term Public Involvement (PI) is preferred
over Patient and Public Involvement (PPI). With the re-
lease of the National Standards for Public Involvement
and the focus on inclusivity, using the term PI is seen as
more reflective of the standards and the fact public in-
volvement is not limited to just patients but includes
carers and members of all communities in research [6].
Different terms are used in other countries, such as ‘con-
sumer involvement’ or ‘public engagement’ [7].
Including the public as advisors (rather than partici-
pants) in research has become increasingly embedded
within health and social care research. Guidance and
standards are available to support researchers in achiev-
ing effective public involvement [5, 6]. Members of the
public may contribute, for example, by commenting on
study design, informing the selection of outcome mea-
sures, reviewing patient information sheets and consent
procedures, making suggestions about data collection
methods and advising on follow up processes [8]. The
incorporation of PI into healthcare research is part of a
family of participatory research methods which aim to
transfer power from the researcher to the research par-
ticipant giving them control of the research agenda, the
process and future actions [9]. Within PROM develop-
ment, PI in has allowed individuals to be included as
part of a research team. By its definition, PI is research
being carried out ‘with’ or ‘by’ members of the public,
rather than ‘to’, ‘about’ or ‘for’ them [10]. There can be
differences between the perspectives of researchers and
those who expect to benefit from research (i.e. patients)
on important aspects of the research process, such as
the relevance of outcome measures [11, 12]. PI brings a
“unique perspective” which enriches research [13, 14].
The importance of involving the public in PROM develop-
ment to increase the quality of the developed PROM has
been highlighted by many authors [12, 15, 16]. PI and public
engagement in PROM development and/or health outcomes
research is encouraged by a range of institutions [17, 18],
however this practice is not widespread. A recent systematic
review of the international literature reported that a quarter
of the 193 PROMs (n= 50) included in the review did not in-
clude any PI in their development [19]. There was minimal
involvement in the selection of outcomes to measure within
the PROM (10.9%), and very few cases with involvement in
all stages of the PROM development [19]. However, it should
be noted that there are discrepancies in terminology between
what some researchers refer to as PI and patients as research
participants [20]. PI is not the same as patient participation.
There have been calls for clarity, guidance and consensus on
PI in PROM development [13, 15]. It is clear that more col-
laborative PI needs to become the norm throughout all
stages of co-construction, selection and implementation of
PROMs [21]. Previous studies have demonstrated PI has
benefits in increasing content validity of PROMs, however
there is limited guidance as to what to consider when devel-
oping a new instrument. This paper provides a timely review
and sets out an emerging framework for fully incorporating
public involvement into PROM development. The content is
based upon our own experiences as researchers working with
public representatives in PROM development, rather than a
systematic review of the empirical evidence. We do not in-
tend to be prescriptive rather offer a framework to serve as a
prompt and reference point of stages to consider including
PI when developing a PROM. In the first section, we provide
a guide of where to embed PI in PROM development. The
second section is a discussion of the challenges of PI in
PROM development.
Public involvement and patient-reported outcome
measures
There are potential difficulties in identifying where PI
can occur in the development of a PROM and in the ap-
plication of the range of research methods used. There
are many stages of PROM development (as outlined
below) that could be followed; however, these are not al-
ways undertaken either due to time or financial con-
straints. There are also cases where the target
population for which the PROM is intended may not
lend itself to involvement in all the stages of PROM de-
velopment outlined here (such as in rare health condi-
tions, as discussed later). We have identified where PI
could occur at each stage of PROM development. How-
ever, time and financial limitations may mean that PI
cannot be fully incorporated throughout. Across all
stages of the primary research, PI can assist with under-
standing and interpreting the study findings [22]. The
stages described here identify potential steps that can be
undertaken when developing or refining a PROM. They
are not meant to be prescriptive, and the process may
not always be linear. It should also be noted that PI may
involve input from more than one individual. Involving
more than one person increases the breadth of experi-
ence to the project, allows those involved to support and
encourage each other, and allows for multiple perspec-
tives. PI members cannot be representative of everyone
who has a specific condition [23, 24]. Having a PI team
is beneficial to allow for wider diversity and experiences.
The stages are summarised in Fig. 1.
Establishing a need for a new or refined PROM
The first stage in which PI may occur is when consider-
ing if a new PROM is necessary. There are many exam-
ples of PI instigating research in key areas, and
initiatives such as the James Lind Alliance [25] in the
UK and Patient-Centred Outcomes Research Institute
[26] have facilitated joint partnerships with patients and
clinicians to prioritise treatment uncertainties for
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research. PI can be useful in reviewing the quality of
existing PROMs, critiquing them in terms of content
and applicability, and suggesting whether a new measure
should be developed [12, 21].
Development of a conceptual model
If a new or refined PROM is required, researchers may
devise a conceptual model for the PROM: the specific
measurement goal and the domains or themes that the
Fig. 1 Public involvement in different stages of PROM development
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questionnaire should cover. The conceptual model may
be informed by existing literature and clinical opinion,
however PI can be incorporated to ensure validity and
provide a sense check of the literature [21].
Identifying item content
Traditionally the content of PROMs was informed by the lit-
erature and/or clinical opinion [27]. Over recent years there
has been an increasing commitment to identify potential
items (questions) and themes through qualitative methods
with the target population. Interviews or focus groups with
people for whom the PROM is intended can be conducted to
identify exactly how that health condition impacts upon an
individual’s quality of life. The transcripts of the qualitative
work can be analysed to identify themes that can be matched
to the conceptual model (which helps to validate the model)
or used to refine the model. Furthermore, the language used
by the participants can be used later in Stage 4 to phrase po-
tential items to be included in the PROM. This stage typically
involves patients as research participants and would not be
considered PI. However, at any stage in which patients (or
the public) are included as research participants there is also
an important role for PI in providing advice. PI involvement
ensures that the best data is generated to support the PROM
development and helps mitigate against some of the ethical is-
sues that surround measure development. The key role for PI
in Stage 3 is ensuring it is relevant to potential research par-
ticipants and carried out in a way that is right for them. PI
can occur in several aspects of Stage 3. Firstly, in designing
the study, PI can identify who would be the most important
group of people to include in the qualitative work (e.g. pa-
tients, carers, clinicians, general population). If patients are
the target population, PI input may include establishing inclu-
sion and exclusion criteria (i.e. which patients to include in
qualitative data collection). Advice on what would be the
most appropriate data collection method (i.e. interviews vs.
focus groups), the timing of interviews, the location, and on
who should conduct the interviews can all be incorporated
[16, 28]. The most appropriate data collection method may
differ from one perspective to another – whilst focus groups
can be more efficient and cost-effective than interviews, they
are not suitable for every topic. Peer (or lay) interviewing has
been used in PROM development [16]. Furthermore, input
on the content of topic guides, information sheets, consent
forms, and all other patient-facing documents and guidance
on any ethical implications of the study (including potential
risks) are all key areas for PI. The PI partners may be able to
provide their own contacts to help with recruitment, such as
links with charities, support groups and/or referrals to com-
munity resources.
Item development
Stage 4 involves taking the results of Stage 3 and word-
ing the quality of life (QoL) concepts and issues into
potential items to be included in the PROM or identify-
ing existing items that capture the concept from item
banks (repository of items) or existing measures. PI can
further ensure the validity of the PROM through analysis
and interpretation of the qualitative data alongside other
members of the research team. Advice can be given on
the wording of the potential items to ensure that lay lan-
guage is used. The wording of items could come either
from PI members or from the transcripts of patients as
research participants (in which case PI can occur as
noted in Stage 3). [The advantages of PI input rather
than that of research participants will concern time and
their broader understanding of the overall project.] Stage
4 will generate a long list of potential items. PI may also
identify any items which could be upsetting or offensive
within the context of the health condition. There is also
potential for PI to help with supporting translation and
cultural adaptation for use in other countries. For ex-
ample, PI could identify any potential difficulties with
translating particular items to other languages if they
themselves are bilingual, or by identifying items which
may be problematic or challenging in different cultures.
Item reduction
In some cases, Stage 4 will generate a list of potential
items that may be too onerous if they were all to be in-
cluded in a piloting or cognitive debriefing stage (Stage
6). PI can be part of a collaborative exercise to develop
the criteria used to identify suitable items and to judge
whether the items meet the criteria. PI can also identify
any potentially redundant items, or indeed reword items
to improve clarity. Advice may also be given concerning
the ordering of the items for Stage 6. This is an area that
can often be overlooked in PROM development. Consid-
eration should be given to the implications of the poten-
tial impact of particular questions to the person
completing the questionnaire, as well as the ordering of
the questions. The ordering of the questions in Stage 5
does not necessarily determine the ordering of questions
within the final PROM.
PI can shed light on how it would feel to be the
patient or individual to experience completing a ques-
tionnaire by commenting on potentially negative ques-
tions (which might make people focus on negative
aspects of their life), positive questions (which might be
upsetting if they appear insensitive), and items which
might seem irrelevant (which might be frustrating). The
explanation and ordering of the questions should be
carefully considered [29].
Pre-testing of items (cognitive interviews and debriefing)
The aim of Stage 6 is to refine and pre-test items before
a larger psychometric survey. PI allows for items, re-
sponse options, and instructions for questionnaire
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completion to be considered. As with Stage 3, PI may in-
clude input on study design and methodology, recruit-
ment, design and content of the public facing
documents, and conducting the interviews themselves
[16]. Further PI may involve analysing or interpreting
the results of the interviews to select the items to in-
clude in the psychometric survey (Stage 7).
Psychometric survey design
The aim of this stage is to test the performance of poten-
tial items when completed by the target population. PI
can be useful in Stage 7, particularly with respect to the
proposed methods of data collection. Advice and guidance
can be given in a number of key areas: the identification of
potential participants; mode of survey administration;
public facing documentation; appropriateness of add-
itional information required for comparison and valid-
ation, including other PROMs and other questions that
could be asked of the respondent to identify the severity
of their health condition; response burden for potential
participants; and the appropriateness and method(s) of
incentivisation. More creative methods of mode of admin-
istration may need to be considered if the PROM is for
particular populations (such as those with language diffi-
culties, learning difficulties and dementia) [30]. PI can
consider the limitations and/or specific needs of partici-
pants, their suitability for the study, eligibility criteria, po-
tential ethical issues related to participating in the
psychometric survey, administration and recruitment.
Psychometric survey analysis
PI in this phase of PROM development can be useful for
the interpretation of results. The different perspectives
offered by PI partners may identify issues missed by re-
searchers, and help to ensure the validity of the findings
from the patient and/or public perspective [16].
Selection of items for the PROM
The final item selection can be informed by combining
information from different sources, such as the results of
the cognitive interviews, the psychometric survey, clin-
ician input, and PI [16]. It is crucial to have PI in Stage 9
to ensure that items are selected not only on their per-
formance, but also on their suitability for the target
population. The number of items to be selected can also
be informed by PI, taking into account the potential re-
sponse burden for those for whom the PROM is de-
signed, and also how the PROM may be used in routine
clinical care.
Design of the PROM (including layout and response
options)
How a PROM is presented (either on paper or online) is
often an under-reported component of PROM development.
PI in Stage 10 is important, so that key issues such as the for-
mat and layout of the questionnaire are designed to be ap-
propriate for the target population. As with Stages 4, 5 and 6,
advice can be given on instructions on how to complete the
questionnaire, suitable wording of response options, framing
of the questions (such as yesterday, last week, last month)
and the order of the items. The order of items in the final
questionnaire is informed by a number of sources, which
may include PI input, clinical opinion and an understanding
of order effects [31].
Dissemination and promotion of the PROM
PI in Stage 11 can engage with the general dissemination
of the measure and, more specifically, promote the role
PI had in its development. Activities such as co-
authorship, co-presenting to various audiences (such as
academics, clinicians, social care professionals, patient
groups and lay audiences), and advising on strategies for
wider dissemination should be encouraged. PI members
can help to ensure materials are written in lay language.
Endorsements from PI participants can help reassure
potential users of the PROM that their voices have been
heard during the development process. This approach
was recently adopted in the development and implemen-
tation of a PROM for users of mental health services
[16, 32].
The stages outlined here have been applied in part,
or in entirety, in other PROM development studies
[12, 16]. The framework outlined here builds upon
existing guidance [5, 6] and includes additional areas
for consideration particularly around dissemination.
Challenges of incorporating PI in PROM development
Whilst PI is recognised as beneficial and best practice, it
must be acknowledged that meaningful PI is not without
its challenges. There can be challenges or negative im-
pacts that are rarely reported, however they do need to
be considered in developing collaborative involvement
initiatives [21]. Below we raise a variety of issues includ-
ing practical, financial and ethical considerations, that
may impact upon effective PI activities.
Need for a clear PI plan The importance of developing
a clear PI plan is essential. The research team needs to
consider the remit of their project, and which stages of
PROM development they will be undertaking. Discus-
sions with PI partners will identify where PI can occur,
and for what purpose. One of the first things to address
is how to recruit PI partners, how many PI members to
include and what skills are needed. For instance, re-
search and interviewing experience will be required for
those PI partners who undertake interviewing. It is more
usual to recruit PI partners who can bring a PI perspec-
tive which reflects the research target population [13].
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There may be established PI groups for the given health
condition, or there may be a need to establish a new PI
group, which should be as diverse as possible. Bagley
et al. [33] highlight potential opportunities for PI in-
volvement in clinical trials research within the United
Kingdom. Although not exhaustive, these could also be
appropriate for PROM development.
It may be that specific training is required for the re-
search team to undertake PI activities [34], and/or train-
ing for the PI members to understand scientific aspects
of PROM development. Having open discussions can
highlight mentoring and support needs as well as accept-
able methods of feedback. Budgeting for PI is necessary
to reimburse people’s time and other expenses, but also
for researcher time to engage with the PI team. In
addition, there should be clarity on both sides around
the expectations in terms of financial compensation and
expected input. The plan should also include details of
how the reporting of PI activities will occur and the ex-
tent to which the impact of PI will be evaluated.
Meeting and involvement practicalities As with any
research project, PI incurs a cost and time commitment
of project staff. The meetings need to be carefully ar-
ranged to consider the needs of the whole PI team. Iden-
tifying those needs in advance is important to maintain
good relationships within the project. Accessibility of
meetings (such as location within a building, proximity
to public transport, and timing), or appropriate use of
technology, should be recognized and negotiated. Other
aspects may include planning of comfort breaks, appro-
priate refreshments, awareness of caring commitments,
and timely reimbursement of PI member’s time and
travel costs [35, 36].
Preparation and delivery of PI tasks The planning and
preparation of meeting materials (such as online re-
sources or handouts) and flexibly responding to PI input
takes considerable researcher time which should be
accounted for within budgets and project timescales.
PROM development faces additional challenges in terms
of the potential complexity of language used by re-
searchers (e.g. psychometric terms), and practical limits
imposed upon the final PROMs (e.g. length, content).
How the scientific considerations of PROM development
including the scope of items, the number of items, and
types of appropriate items that can be included needs to
be carefully explained Skills of chairing, communicating,
managing difficult situations and conflicts of opinions,
understanding and dealing with power relationships
(both between researchers and PI members and within
PI members) are different to other research skills re-
quired in outcomes research, such as those involved in
advanced psychometrics, and PROMs development
teams need to reflect on whether researchers have the
required skills.
Building and sustaining relationships It is important
to build relationships where there is trust and respect,
where everyone within a research team, including PI,
can voice their opinion appropriately [37, 38]. Collabora-
tive relationships such as these can take time to develop,
and this will have an impact upon both the resources
and timeframe of the project [39]. However, it is essen-
tial as without establishing a good partnership PI can ap-
pear tokenistic [40]. Throughout a project, there should
be regular contact and communication between the PI
team and the research team. By doing so it strengthens
the relationship between individuals and can ensure that
genuine shared decisions can occur. Sustaining long-
term commitment and engagement with PI members is
an ideal, providing it is wanted by all parties. There may
be challenges in ensuring genuine shared decision mak-
ing within the restrictions of a grant with pre-
commitment to specific deliverables [41].
Within PROM development it can be very clear if PI
advice is taken forward – particularly at the stage of item
inclusion/reduction. Sustaining positive relationships
whilst not taking forward PI advice (e.g. not including a
theme that a PI member perceives to be important be-
cause it has limited relevance for some patient sub-
groups) requires transparency, and time to ensure PI
members understand the rational for decisions and re-
tain a sense of ownership.
PI is often portrayed as a smooth journey – and this is
not always the case. There can be frustrations on both
sides [16]. PI partners may become frustrated at the for-
mulaic way in which PROMs are developed. The team
meetings themselves may be difficult: trying to ensure
that progress is made whilst allowing people to voice
their opinions and experiences.
Kirwan et al. [42] have developed principles on using
PI in outcomes research, which focus heavily on the im-
portant area of relationship development. There is an in-
creasing acknowledgement within institutions as to the
benefits of PI within research [43, 44]. This has further
been extended within some academic groups to PI part-
ners being part of management and strategic commit-
tees. Such an inclusion has highlighted the need for
positive behaviours of respect and trust, as well as iden-
tifying and addressing training needs and appropriate re-
sources for successful PI.
Ethical implications, wellbeing of PI partners and
appropriate commitment It is important to recognize
that PI partners are not research participants. There are
no official approval requirements to initiate PI activities,
such as ethics or governance approvals; however, there
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are some ethical considerations to consider such as mu-
tual respect, reciprocity, shared commitment, and per-
sonal integrity [45].
As shown in the potential stages of PROM develop-
ment, PI can be a substantial commitment for individ-
uals across the whole project. The emotional wellbeing
of PI participants must be maintained, and the research
team should be mindful of this. There may be cases
where different PI groups could inform different aspects
of the PROM development to avoid overburdening a few
individuals. PROM development is potentially more per-
sonal than other areas of research since it goes to the
heart of understanding quality of life, and the ways in
which peoples’ experiences can be less than optimal.
Immersion within this reality may be emotionally de-
manding for PI partners. This may be particularly acute
for PROM development in life-limiting conditions. Re-
searchers can undergo training on PI facilitation to en-
sure appropriate interactions within team meetings.
Reporting of PI activities Another challenge of PI in
PROM development concerns the reporting of PI activ-
ities themselves, which recent initiatives have encour-
aged [46, 47]. The Guidance for Reporting Involvement
of Patients and Public checklist (GRIPP) was a key driver
in better reporting of PI in research studies [46]. The
GRIPP2 checklist has further encouraged formal evalu-
ation of PI activities in research. The development of the
short and long form checklists both aim to improve the
quality, transparency and consistency of the reporting of
PI [47].
Whilst better reporting has been encouraged, aca-
demic journals do limit the number of words for article
submissions (usually allowing additional online supple-
mentary material). This places authors in the difficult
position of deciding what to report as core when dissem-
inating their research, and in some instances the role of
PI within a research project may not always be fully re-
ported. There have been pledges to support the report-
ing of PI. The British Medical Journal and its portfolio
of journals have extended their requirements in report-
ing PI in the design, conduct and reporting of clinical
studies [48]. However it is not yet clear how effective
this will be, or whether allowances in word count will be
altered to reflect the addition of these details. Within
PROM development, project timescales and budgets re-
late to a specific time-limited project. However, dissem-
ination, particularly paper writing, often occurs beyond
budget timescales, creating challenges for compensated
PI. Reporting of PI activities is important if the impact
of PI is to be recognized by research funders.
In the reporting of PROM development researchers
should clearly distinguish between patients as PI where
they are co-producing the instrument versus patients as
research participants. In PROM development the line
may be blurred. For example, a focus group could be
held to discuss instrument layout with a sample of pa-
tients as research participants or with a PI group. The
content of the discussion in this case would be very
similar. Pandya-Wood and colleagues [49] acknowledge
that if verbal contributions arising from PI consultations
are to be treated as research data then ethical approval
should be sought.
Developing instruments for children or those with
limited capacity To date there has been little guidance
on how best to incorporate PI with those under the age
of 16 years as well as those with limited capacity in
PROM development [50]. A recent mapping exercise ex-
plored the process of involving children and young
people as research advisers. It highlighted some funda-
mental barriers that make meaningful involvement diffi-
cult: time, money and gatekeepers. Involvement with
communities is key, and there is increasing emphasis on
the role of shared decision-making in clinical care yet
has been little direction on how to achieve this. Consid-
ering the potential stages of PROM development de-
tailed in Fig. 1, it is not easy to implement PI with
children at every stage. Researchers need to consider
where meaningful PI can occur, and ways to suitably in-
volve the PI team [51]. Traditional approaches may have
to be replaced by innovative methods of initiating dis-
cussion, such as interactive play, learning technologies,
communication aids and social media [52].
Developing instruments for very rare conditions PI
for very rare conditions raises issues relating to anonym-
ity. Within a small patient community, PI members may
recognize the identity of anonymised respondents via their
characteristics e.g. age/gender/health or condition-stage.
Furthermore, PI is likely to be inconsistent with participa-
tion in the research project, as undertaking both roles is
usually avoided where possible. This is in part due to risks
of affecting upon the power dynamics and sense of owner-
ship of research findings, and undermining a clear meth-
odology for sampling and recruitment, however, it may be
beneficial in some circumstances [53].
The use of PI in international PROM development
Developing a single PROM which is valid across different
languages, cultures and countries raises its own chal-
lenges, including locally driven concerns and interpreta-
tions of concepts [54]. Including PI within international
PROM development cannot overcome these inherent dif-
ficulties. A potential tension also exists between PI as re-
search partners in one local context, and advising on the
research methods, and final PROM, versus achieving
consistency in methods and outcome across different
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areas. Working in international collaboration may present
additional considerations for PI groups including coordin-
ation and potential compromise where consistency in
methods is deemed necessary. However, the need for local
PI involvement is necessary to avoid research being ap-
plied to different context without appropriate adaptation.
Developing instruments for use in preference-based
measures Some PROMs can be used to generate Quality
Adjusted Life Years used in economic evaluations of
treatments [55]. Such instruments require the health
states described by the PROM to be valued based on
preferences of the public or patients using preference-
elicitation tasks. The methods undertaken to obtain pa-
tient or public preferences are in themselves complex,
and as such they bring additional requirements (or limi-
tations) for a PROM. The PROM cannot be too long,
must be completed in its entirety (i.e. there needs to be
no missing values or non-relevant questions), and it is
restricted to items which will work well within the
preference-elicitation tasks. It adds a further complexity
to PROM development that would need careful commu-
nication to the PI group.
Ensuring optimum PI within PRO development
There is often pressure on researchers and funders of re-
search to undertake and complete research efficiently.
Therefore optimizing PI within PROM development will
be essential when considering the timescales of a project.
There may be concerns regarding the investment in par-
ticular components of PI in the PROM development
process. Groene [56] discuss the complexity of interpret-
ing some psychometric data used in the development of
PROMs, and the extensive training costs required for
meaningful PI in this area [57]. The balance between in-
vestments in PI members versus benefit to the PROM
development may differ across projects and the stages of
development. Consideration should also be made to
which stages PI occurs. For instance, it is possible to
have different PI groups for different stages to try and
minimise burden. It must be remembered that for each
new PI group, there may have to be training or de-
briefing of previous stages of the PROM development.
Conclusion
We present an emerging framework identifying ways in
which PI can have a meaningful role and contribution to
the co-development of PROMs. Incorporating PI is an im-
portant part of the development process, and its inclusion
contributes to strengthening the relevance, acceptability
and validity of the PROM itself. The framework is not pre-
scriptive as the sequence of PROM development is not
uniform. The type and level of PI will vary between stud-
ies. As with PI in general, the earlier that PI can be
initiated, the more scope there will be for the PROM to
reflect the concerns of the target group and be ethically
acceptable. It should be acknowledged that the stages out-
lined here are based upon our own experiences as instru-
ment developers. We provide a figure to act as a prompt
of issues to consider when developing PROMs, so that re-
searchers can use this as a quick reference point of areas
to consider. The emerging framework is a response to re-
quests for clarity, guidance and consensus on PI in PROM
development and provides a contribution to the ongoing
dialogue.
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